Trademarkia Logo

Canada

C$
EMPOWERING LIFE
REGISTERED

on 9 Jan 2024

Last Applicant/ Owned by

SANOFI

46 avenue de la Grande ArméeParis, 75017

FR

Serial Number

1773654 filed on 22nd Mar 2016

Registration Number

TMA1217774 registered on 9th Jan 2024

Registration expiry Date

9th Jan 2034

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

EMPOWERING LIFE

Trademark usage description

chemical preparations for medical or pharmaceutical purposes, namely, chemicals for use in the manufacture of pharmaceutical preparations. house mark Read More

Classification Information


Class [001]
Chemical preparations for medical or pharmaceutical purposes, namely, chemicals for use in the manufacture of pharmaceutical preparations.


Classification kind code

11

Class [005]
House mark for a full line of pharmaceutical and medicinal products and substances, both prescription and over-the-counter, sanitary preparations for medical purposes and dietetic substances adapted for medical use, for both human and veterinary use namely, pharmaceutical preparations for the prevention and treatment of psychiatric diseases, degenerative nerve diseases and brain disorders, namely, mood, anxiety and cognitive disorders, Alzheimer's disease, cerebral palsy, Parkinson's disease, Huntington's disease and multiple sclerosis; Pharmaceutical preparations for the prevention and treatment of cranial and facial nerve disorders, connective tissue injuries, diseases and disorders, bone and cartilage injuries, diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neuromuscular and neurological diseases and disorders, namely, central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, muscle diseases and disorders, namely inflammatory muscle diseases and disorders, and muscular dystrophy, ocular motility and spinal cord infections, injuries and diseases, and seizure disorders; Pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, inflammatory pelvic diseases, urological and reproductive system diseases, disorders and infections, namely, sexually transmitted diseases, erectile and sexual dysfunction, infertility and incontinence; Pharmaceutical preparations for the prevention and treatment of auto-immune, cardiovascular, gastrointestinal, hematologic, oncological, ophthalmological and respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of allergies, hypertension, menopause, diabetic neuropathy, arthritis, and pain; Antibiotics, anti-infectives, anti-inflammatories, anti-fungals, anti-virals, oral and injectable pharmaceutical contraceptives, human vaccines; Pharmaceutical preparations for the prevention and treatment of smoking habits and addictions; Pharmaceutical preparations for the prevention and treatment of renal disease and disorders; Pharmaceutical preparations for the prevention and treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; Pharmaceutical preparations for the prevention and treatment of muscular atrophy; Pharmaceutical preparations for the prevention and treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders; Pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, hypoglycemia, muscular dystrophy, sickle cell disease, and anemia; pharmaceutical preparations for the prevention and treatment of rare blood disease; all purpose disinfectants; food for babies; plasters, namely, adhesive plasters for medical purposes and surgical plasters; materials for dressings, namely, bandages for dressings, wadding for dressings, and surgical dressings; material for dental fillings and dental impressions; preparations for destroying noxious animals; fungicides, herbicides


Classification kind code

11

Class [035]
Business management consulting in the field of healthcare; distribution of printed promotional materials in the pharmaceutical field to practitioners and patients.


Classification kind code

11

Class [042]
Research in the fields of medicine, biologic pharmaceuticals and pharmacy, and providing advice, scientific and technical information in the fields of medicine, biologic pharmaceuticals and pharmacy; laboratories for chemical analysis, pharmaceutical research, homeopathy research, dietetic and nutritional products research, chemical research; research services for the development of new products, namely, conducting clinical trials, research and investigations, scientific and medical research, development protocols and medical experiments in the field of pharmaceutical preparations and their development, and providing medical research assistance to medical researchers namely organization of research groups in the medical area, conducting clinical test research in the medicine area; medical services, namely, medical laboratory services and medical testing services.


Classification kind code

11

Class [044]
Veterinary services; consulting services regarding public health counselling and the diagnosis and treatment of diseases and disorders; diagnostic and medical testing services; pharmacy consulting.


Classification kind code

11

Mark Details


Serial Number

1773654

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 15
on 31st May 2019
Correspondence Created
Submitted for opposition 15
on 1st Apr 2019
Correspondence Created
Submitted for opposition 12
on 25th Sept 2018
Extension of Time
Submitted for opposition 15
on 13th Mar 2018
Correspondence Created
Submitted for opposition 12
on 20th Mar 2017
Extension of Time
Submitted for opposition 22
on 13th Sept 2016
Search Recorded
Submitted for opposition 20
on 13th Sept 2016
Examiner's First Report
Submitted for opposition 31
on 24th Mar 2016
Formalized
Submitted for opposition 1
on 23rd Mar 2016
Created
Submitted for opposition 30
on 22nd Mar 2016
Filed